Infectio (Aug 2021)

Tigeciclina intraventricular como tratamiento de ventriculitis por Chryseobacterium indologenes multirresistente. A propósito de un caso pediátrico

  • Gloria Celeste Samudio-Domínguez

DOI
https://doi.org/10.22354/in.v26i1.999
Journal volume & issue
Vol. 26, no. 1
pp. 83 – 86

Abstract

Read online

Ventriculitis due to Chryseobacterium indologenes can be a major therapeutic challenge, especially when the germ acquires intra-treatment resistance to common antimicrobials. Intraventricular tigecycline could be an excellent option in these cases. We present a schoolgirl`s case who received successfully intraventricular treatment with tigecycline.

Keywords